1-2 of 2
Jonathan Canaani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial eligibility, treatment patterns and outcome for venetoclax-based therapy in AML: a prospective cohort study

Clinical Trials & Observations
Ofir Wolach, Itai Levi, Boaz Nachmias, Sigal Tavor, irina Amitai, Yishai Ofran, Chezi Ganzel, Tsila Zuckerman, Doaa Okasha, Ilana Hellmann, Tamar Tadmor, Najib Dally, Jonathan Canaani, Galia Stemer, Moshe Grunspan, Adi Jacob Berger, Neta Frankel, Jenia Berelovich, Alexandra Bleterman, Moran Barak, Raanan Cohen, Yakir Moshe
Journal: Blood Advances
Blood Adv bloodadvances.2024014014.
https://doi.org/10.1182/bloodadvances.2024014014
Published: 2024
Includes: Supplemental data
Journal Articles

Gilteritinib induces differentiation in relapsed and refractory FLT3 -mutated acute myeloid leukemia

Clinical Trials & Observations
Christine M. McMahon, Jonathan Canaani, Bryan Rea, Rachel L. Sargent, Julianne N. Qualtieri, Christopher D. Watt, Jennifer J. D. Morrissette, Martin Carroll, Alexander E. Perl
Journal: Blood Advances
Blood Adv (2019) 3 (10): 1581–1585.
https://doi.org/10.1182/bloodadvances.2018029496
Published: 2019
Includes: Supplemental data